LILLIAN CARR: Open Payments
NPI 1154751600 · EAST BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 27 payments from 12 companies in 2025. Trend: 2023 $381 · 2024 $232 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $161 |
| ABBVIE INC. | 5 | $77 |
| Lilly USA, LLC | 3 | $50 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Abbott Laboratories | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: LINZESS, Ozempic, Wegovy, Rybelsus, KISUNLA, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
